Submitted by Anonymous (not verified) on 15 October 2024 - 14:32
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 5, Status: Authorised